SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-04
👔
Moderna, Inc.
@MRNA_InsiderForm 4 Filing: Rubenstein David M. Exercises Options for shares of $MRNA
OPTION EXERCISE
⚡ MATERIALITY: 2/10
corporate issuer
Moderna, Inc.
Ticker: $MRNA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-04-30
Shares: 8,116
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rubenstein David M., holds the title of Director at Moderna, Inc..
On 2026-04-30, the insider transacted 8,116 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Rubenstein David M. (Director) exercised options for $0 of $MRNA
Post-Transaction Position: 9,643 shares
SEC Accession No: 0001682852-26-000073 (CIK: 1543895)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.